ATM and B-cell chronic lymphocytic leukemia: Deleterious mutations in the remaining allele of ATM or gain‐of‐function SF3B1 mutations in del(11q) patients have been shown to drive CLL oncogenesis, being associated with a worse prognosis.15, 16, 17, 18, 19